T
Takeru Higuchi
Researcher at University of Wisconsin-Madison
Publications - 206
Citations - 11538
Takeru Higuchi is an academic researcher from University of Wisconsin-Madison. The author has contributed to research in topics: Aqueous solution & Solubility. The author has an hindex of 37, co-authored 206 publications receiving 11032 citations. Previous affiliations of Takeru Higuchi include Smith, Kline & French & Merck & Co..
Papers
More filters
Journal ArticleDOI
Study of possible complex formation between macromolecules and certain pharmaceuticals. III. Interaction of polyethylene glycols with several organic acids.
Takeru Higuchi,John L. Lach +1 more
TL;DR: It is shown by another phase analytical method that phenolic compounds are bound by the polyethers in the same fashion, the higher molecular weight polymers exhibiting greater complexing tendency than those of lower degrees of polymerization.
Journal ArticleDOI
Direct potentiometric and titrimetric determination of methadone in urine with plastic electrodes selectiive for hydrophobic cations.
Journal ArticleDOI
The Physics of Tablet Compression XI.:Determination of Porosity of Tablet Granulations
TL;DR: The results indicate that granulations prepared by the wet granulation method, using starch paste, had approximately 30% void space, while aspirin granulation, prepared byThe slugging process, had about 3% voidspace.
Journal ArticleDOI
N‐halo derivatives III: Stabilization of nitrogen‐chlorine bond in N‐chloroamino acid derivatives
TL;DR: A series of low chlorine potential, soft antimicrobial N-chloramines was developed based on derivatives of alpha-aminoisobutyric acid and related compounds based on the stability and reactivity of the nitrogen-chlorine bond in these N- chloramines.
Journal ArticleDOI
Improved delivery through biological membranes. 2. Distribution, excretion, and metabolism of N-methyl-1,6-dihydropyridine-2-carbaldoxime hydrochloride, a pro-drug of N-methylpyridinium-2-carbaldoxime chloride.
TL;DR: N-Methyl-1,6-dihydropyridine-2-carbaldoxime hydrochloride, the pro-drug of 2- PAM, was found to be converted in vivo to 2-PAM, rapidly and quantitatively.